Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 1,598 shares at $323.62 ($524K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Open-market sale of $524k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $323.62 | 47 | $15K | 2.9% |
| 2 | $324.65 | 90 | $29K | 5.6% |
| 3 | $325.63 | 258 | $84K | 16.0% |
| 4 | $326.81 | 392 | $128K | 24.5% |
| 5 | $327.67 | 329 | $108K | 20.6% |
| 6 | $328.71 | 100 |
| $33K |
| 6.3% |
| 7 | $329.71 | 170 | $56K | 10.7% |
| 8 | $330.85 | 81 | $27K | 5.1% |
| 9 | $331.93 | 94 | $31K | 6.0% |
| 10 | $332.64 | 37 | $12K | 2.4% |
| Total | $327.65 avg | 1,598 | $524K | 100% |
| Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |
| ALNY | SELL | 2025-09-02 | $3.1M | — | Filing → |